AI-Designed Cancer Engagers
1:54:30–1:55:45 · 75s
Marson shares how pharma is now using AI to design synthetic, two-headed protein engagers that bring T cells to tumors—custom targets engineered in silico.
1:54:30–1:55:45 · 75s
Marson shares how pharma is now using AI to design synthetic, two-headed protein engagers that bring T cells to tumors—custom targets engineered in silico.
We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.